Facebook Twitter RSS Feed
 - blood, clot, vein, platelet

An FDA advisory panel voted 9-1 in favor of approval of the anticoagulant edoxaban to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

 - deal

Abbott will buy two companies that develop electrophysiology products in a move designed to make Abbott a player in the catheter-based electrophysiology market. It also named a chief to lead the business.

 - bleeding_stroke

CT angiography ousted digital subtraction angiography as the most cost-effective modality for diagnosing certain bleeding strokes in an analysis that took into account the prowess of modern scanners. 

 - Storm

Cardiovascular device makers may need to brace and embrace to stay afloat, according one market projection. Analysts predicted a 6 percent decline in margins for medical device companies by 2020, which could be offset by $34 billion in profits and cost reductions.

 - doctor texting

An acute ischemic stroke intervention turned a simple text system into significant improvements in door-to-needle times for one center, according to a study published online Oct. 28 in Stroke.